Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
Study NCT ID:
NCT02857920
Status:
COMPLETED
Last Update Posted:
2020-09-14
First Post:
2016-08-03
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Combination of Bevacizumab and Allogeneic NK Immunotherapy for Metastatic Solid Tumors
Sponsor:
Fuda Cancer Hospital, Guangzhou
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-03
First Submit QC Date:
None
Study First Post Date:
2016-08-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-10
Last Update Post Date:
2020-09-14
Last Update Post Date Type:
ACTUAL